NDC 50090-5835

SEMGLEE

Insulin Glargine

SEMGLEE is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Insulin Glargine.

• Product ID: 50090-5835_243d739f-8628-44e1-bad0-1d9a01a55f2b
• NDC: 50090-5835
• Product Type: Human Prescription Drug
• Proprietary Name: SEMGLEE
• Generic Name: Insulin Glargine
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2020-08-31
• Marketing Category: BLA /
• Application Number: BLA210605
• Labeler Name: A-S Medication Solutions
• Substance Name: INSULIN GLARGINE
• Active Ingredient Strength: 100 [iU]/mL
• Pharm Classes: Insulin [CS],Insulin Analog [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 50090-5835-0

1 VIAL in 1 CARTON (50090-5835-0) > 10 mL in 1 VIAL

• Marketing Start Date: 2021-10-28
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "SEMGLEE" or generic name "Insulin Glargine"

NDC	Brand Name	Generic Name
49502-195	SEMGLEE	SEMGLEE
49502-196	SEMGLEE	SEMGLEE
0002-7715	BASAGLAR	Insulin glargine
0002-8214	BASAGLAR	Insulin glargine
0088-2220	Lantus	insulin glargine
0088-2219	Lantus Solostar	insulin glargine
0024-5869	TOUJEO	insulin glargine
0024-5871	TOUJEO Max	insulin glargine